442 related articles for article (PubMed ID: 11051618)
41. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
Dabernat H; Delmas C; Lareng MB
Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
[TBL] [Abstract][Full Text] [Related]
42. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
Richmond MH
Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
[TBL] [Abstract][Full Text] [Related]
43. [In vitro activity of beta-lactam antibiotics and their sensitivity to beta-lactamase].
Esposito S; Galante D; Pennucci C; Scioli C
Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1674-7. PubMed ID: 6365119
[TBL] [Abstract][Full Text] [Related]
44. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
Cui WL; Xu DX; Li WL; Wang LX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
[TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
[TBL] [Abstract][Full Text] [Related]
47. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Søraas A; Sundsfjord A; Jørgensen SB; Liestøl K; Jenum PA
PLoS One; 2014; 9(1):e85889. PubMed ID: 24454943
[TBL] [Abstract][Full Text] [Related]
48. Defining an extended-spectrum beta-lactamase.
Livermore DM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
[TBL] [Abstract][Full Text] [Related]
50. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
51. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
Zhao WH; Asano N; Hu ZQ; Shimamura T
J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
[TBL] [Abstract][Full Text] [Related]
52. Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota.
Karami N; Hannoun C; Adlerberth I; Wold AE
J Antimicrob Chemother; 2008 Oct; 62(4):703-8. PubMed ID: 18583327
[TBL] [Abstract][Full Text] [Related]
53. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.
Costa D; Vinué L; Poeta P; Coelho AC; Matos M; Sáenz Y; Somalo S; Zarazaga M; Rodrigues J; Torres C
Vet Microbiol; 2009 Sep; 138(3-4):339-44. PubMed ID: 19372011
[TBL] [Abstract][Full Text] [Related]
55. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
[TBL] [Abstract][Full Text] [Related]
56. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.
Kim SH; Wei CI
J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200
[TBL] [Abstract][Full Text] [Related]
57. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.
Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422
[TBL] [Abstract][Full Text] [Related]
58. Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes.
Bert F; Juvin M; Ould-Hocine Z; Clarebout G; Keller E; Lambert N; Arlet G
J Clin Microbiol; 2005 Apr; 43(4):1846-50. PubMed ID: 15815007
[TBL] [Abstract][Full Text] [Related]
59. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
Thulin E; Thulin M; Andersson DI
EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
[TBL] [Abstract][Full Text] [Related]
60. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
